3BBLACKBIO.BO
3B BlackBio Dx Limited
₹1244.05
+1.52%
2026-05-29
About 3B BlackBio Dx Limited
3B Blackbio Dx Limited engages in the design, development, manufacturing, and commercialization of molecular diagnostic solutions for infectious diseases, oncology, human genetics and antimicrobial resistance in India. The company offers qPCR-based and lateral flow assays rapid tests and Next Gen Sequencing -based molecular diagnostic kits for accurate and reliable testing on patient samples under the TRUPCR, TRUNGS, TRURAPID, brand for testing on patient samples to diagnostics labs. It also offers agrochemical products; technical support and training services. 3B Blackbio Dx Limited was incorporated in 1972 and is headquartered in Bhopal, India.
Key Fundamentals
P/E Ratio
19.45
EPS (TTM)
₹66.54
Revenue Growth (YoY)
98.3%
Profit Margin
44.6%
Debt/Equity
0.09
Dividend Yield
0.3%
Price/Book
3.64
Beta
0.40
Market Cap
₹11.11B
Avg Volume (10D)
5K
Recent Breakout Signals
No recent breakout signals detected for 3BBLACKBIO.BO.
Recent Price Range (60 Days)
60D High
₹1553.00
60D Low
₹1110.00
Avg Volume
10K
Latest Close
₹1244.05
Get breakout alerts for 3BBLACKBIO.BO
Sign up for Breakout Scanner to receive daily notifications when 3BBLACKBIO.BO triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
3B BlackBio Dx Limited (3BBLACKBIO.BO) is listed on the Bombay Stock Exchange (BSE). Breakout Scanner monitors 3BBLACKBIO.BO daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 3BBLACKBIO.BO operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.